InvestorsHub Logo
Followers 53
Posts 3355
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Monday, 03/13/2017 8:07:14 PM

Monday, March 13, 2017 8:07:14 PM

Post# of 3283
The Games People (and Tutes) Play. Before I get rid of this info I wanted to post it. Here’s 2 Seeking Alpha alerts, one at 4:04 PM after the PR on Earnings release came out last Wed and the other an hour later.

Spectrum Pharmaceuticals beats by $0.03, beats on revenue
Mar. 8, 2017 4:04 PM ET|About: Spectrum Pharmaceutical... (SPPI)|By: Mohit Manghnani, SA News Editor
Spectrum Pharmaceuticals (NASDAQ:SPPI): Q4 EPS of -$0.10 beats by $0.03.
Revenue of $35.2M (-30.1% Y/Y) beats by $4.07M.


Spectrum Pharma Q4 top line down 30%, net loss widens; shares down 15% after hours
Mar. 8, 2017 5:07 PM ET|About: Spectrum Pharmaceutica... (SPPI)|By: Douglas W. House, SA News Editor
Spectrum Pharmaceuticals (NASDAQ:SPPI) Q4 results ($M): Total Revenues: 35.2 (-30.0%); Product Sales: 32.2 (-7.5%).
Net Loss: (17.4) (-314.3%); Non-GAAP Net Loss: (8.1) (-76.1%); Loss/Share: (0.22) (-266.7%); Non-GAAP Loss/Share: (0.10) (-42.9%).
BLA filing in U.S. for ROLONTIS expected in 2018.
Results from investigator-sponsored study of poziotinib in NSCLC expected by year end.
Special protocol assessment received from FDA related to Phase 3 study of Qapzola in non-muscle invasive bladder cancer.
Shares are off 15% after hours on average volume.

What a difference between the 2 alerts. The 1st one is what we normally see and the 2nd one preaching that 'All is Lost' kind of tone. Too funny.